ANI Pharmaceuticals Inc

NASDAQ:ANIPUnited States

ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company, which serves patients in need by developing, manufacturing and marketing branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel, as well as its generics business with enhanced research and development capabilities. Its three pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota, and one is located in East Windsor, New Jersey, are together capable of producing oral solid dose products, as well as semi-solids, liquids and topicals, controlled substances, and potent products. The Company has a commercial portfolio of approximately 118 products with a variety of indications and a robust portfolio of pipeline products.

Contact Information

Headquarters

210 Main Street WestBAUDETTE, MN, United States 56623

Phone

218-634-3500

Fax

218-634-3540

Executives

Independent Chairman of the Board

Patrick Walsh

President, Chief Executive Officer, Director

Nikhil Lalwani

Chief Financial Officer, Senior Vice President

Stephen Carey

Chief Human Resource Officer, Senior Vice President

Krista Davis

Senior Vice President, General Counsel, Corporate Secretary

Meredith Cook